Why Vendor Oversight Breaks Down At Handoffs

By Pawankumar Suresh

Vendor oversight often weakens after a handoff looks complete.

A sponsor may receive the file. A CRO may close a tracker item. A specialty vendor may send the data set, report, reconciliation package, or status update on time. The handoff appears complete, but the real test is whether the receiving team can use the output without reconstructing context, chasing missing decisions, or asking who owns the next step. This is where oversight often breaks down. Handoffs are treated as transfers of work rather than a transfer of context, ownership, and next-step clarity.

In clinical development, sponsors delegate tasks but often do not delegate the need to understand whether the work is complete, reliable, and ready for the next decision. Vendor oversight therefore needs to look beyond whether something was delivered. It needs to ask whether the handoff preserved enough context for the next team to act. I have seen this distinction matter most when work moves across clinical operations, quality, regulatory, CMC, and external partners. In those moments, the issue is rarely that no one is working hard. The issue is that each team may be solving its part of the problem while the overall handoff story remains incomplete.

Where The Handoffs Happen

Vendor handoffs occur across the full operating chain of a study. A sponsor may delegate study-execution responsibilities to a CRO, which may then work with laboratories, imaging vendors, eCOA providers, data management partners, safety vendors, or other specialty providers. Those vendors send outputs back through the CRO or directly to sponsor functions. Internally, clinical operations may then need to hand information to quality, regulatory, medical, clinical supply, data management, or inspection readiness teams.

Each step may be reasonable on its own. The problem appears when the receiving team gets the deliverable but not the operating context behind it.

For example, a vendor may submit a report that is technically complete but does not clearly explain open assumptions. A CRO may escalate a risk after the practical options have narrowed. A clinical team may call a document final before quality or regulatory reviewers can understand the rationale behind key decisions. A tracker may show that an action is closed, while the evidence needed for inspection or review is still scattered across email, minutes, and working files.

The effort is clearly there, but just as clear are the problems with how the handoff was set up.

Sent Is Not The Same As Usable

One of the most common oversight traps is treating delivery as closure. A file was sent. A meeting was held. A tracker was updated. A vendor confirmed completion. These signals can be useful, but they do not prove that the receiving team has what it needs.

A handoff is complete only when the next team can answer a few basic questions: What changed? What remains open? What assumptions were made? What decision is needed? Who owns follow-up? What evidence supports the conclusion?

If the receiving team has to rebuild that story, the handoff is not complete. It has merely shifted the burden downstream. In cross-functional program work, I have found that the downstream burden often shows up quietly at first: an extra clarification email, a side conversation before a review, a reviewer asking for the rationale behind a decision that everyone assumed was already clear. Those small gaps become much harder to fix when the work is closer to an audit, database milestone, submission, or inspection readiness review.

What Sponsors Should Watch Earlier

Sponsor oversight does not need to become heavier, just more specific. Instead of asking only whether a vendor deliverable is on track, sponsors can ask whether the handoff is usable. Useful questions include:

• Is the deliverable tied to a clear owner on both the sending and receiving sides?
• Are open assumptions, unresolved risks, and pending decisions stated plainly?
• Can the receiving team use the output without searching across multiple systems or email threads?
• Does the handoff make downstream quality, regulatory, data, or inspection needs visible?
• If the work were reviewed tomorrow, would the rationale be easy to explain?

These questions are simple, but they change the conversation by shifting the focus from whether work is moving to whether work is moving in a way that can be used and defended.

The Role Of Governance

Governance forums should reduce ambiguity at handoffs, not simply collect updates.

A vendor governance meeting that only reviews status may miss the real risk. The most useful governance discussions I have been part of were the ones where the team could say plainly: This is the decision needed, this is who owns it, this is the evidence we have, and this is what remains unresolved. “On track,” “pending review,” or “awaiting vendor response” may be accurate, but those phrases do not show whether the work is decision-ready. They do not clarify what the receiving team needs, what risk is building, or what will happen if the handoff remains incomplete.

A stronger governance review should make three things visible: the decision, the owner, and the evidence. If any of those are unclear, the handoff deserves more attention.

This can be handled through better meeting discipline, cleaner action language, sharper escalation thresholds, and handoff criteria that define what “complete” means for the next team, not only for the sending team.

Making Handoffs Work

A practical handoff process should be simple enough for teams to use but clear enough to prevent rework. For high-risk or inspection-facing work, teams can define minimum handoff expectations: the deliverable, the current version, the owner, known gaps, assumptions, related decisions, downstream users, and the date by which follow-up is needed. The goal is not to add paperwork but to prevent every receiving team from rebuilding the same context under deadline pressure.

This is especially useful when multiple vendors support the same study or when work moves between clinical operations, quality, regulatory, safety, and data functions. Those groups may use different language and care about different risks. A good handoff translates the work enough for the next function to act without guessing.

The best vendor oversight often comes down to this: Do not only manage the vendor’s activity; manage the points where the vendor’s work becomes someone else’s responsibility.

A Practical Takeaway

Vendor oversight breaks down when teams mistake movement for control. A deliverable can be sent on time and still be incomplete for the team that must use it. Before closing a vendor action or accepting a handoff, sponsors should ask one practical question: Can the next team use this without reconstructing the story? If the answer is no, the handoff is not finished. And if that gap is visible during routine execution, teams still have time to fix it before it becomes a review, audit, or inspection problem.

About The Author:

Pawankumar Suresh, MS, CSM, is a biopharma program and technical operations leader with experience across clinical operations, CMC, regulatory readiness, quality systems, vendor oversight, and cross-functional execution in regulated development environments. His work has included outsourced partner governance, inspection-readiness planning, regulatory submission support, and execution oversight across clinical-stage and commercial biopharmaceutical programs.